DLG4 and major depressive disorder: Several studies have shown that the disruption of PSD-95 in depression inhibits the production of nNOS-derived free radicals and reduces excitotoxicity by blocking the signaling of calcium-ion-activated N-methyl-D-aspartate receptors in the amygdala [68, 69].